SCHEMBL26100672

SCHEMBL26100672

c1ccc(-c2ccc(-c3ccccc3)c(-c3ccc(N(c4ccc(-c5ccc6ccccc6c5)cc4)c4ccccc4-c4cccc(-c5ccc6ccccc6c5)c4)cc3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
ESR1 P03372 3/20 0.37
ESR2 Q92731 3/20 0.37
GSTP1 P09211 1/20 0.37
MEN1 O00255 1/20 0.36
APAF1 O14727 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
XBP1 P17861 1/20 0.36
PTBP1 P26599 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
GALK1 P51570 1/20 0.36
BLM P54132 1/20 0.36
SMAD3 P84022 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25000734 0.99 HSD17B1 (0.40) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL25628860 0.97 ESR1 (0.39) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24999202 0.97 ESR1 (0.39) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24861936 0.96 ESR1 (0.40) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL30308523 0.96 ESR1 (0.40) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL23179380 0.95 HSD17B1 (0.42) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL23180366 0.95 HSD17B1 (0.42) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL23179346 0.93 HSD17B1 (0.44) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24841658 0.93 HSD17B1 (0.44) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24842299 0.93 HSD17B1 (0.44) HSD17B1HSD17B2ESR1ESR2GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138055-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138055-A1 ORGANIC ELECTROLUMINESCENT DEVICE SLC7A5, SLCO4C1, SLC43A1 HSD17B1 2525/4885HSD17B2 1800/4885ESR1 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.